Jubilant Pharmova (JUBLPHARMA) — Board Meeting

📢 Key Event
Board approved unaudited Q1 FY2026 financial results

💡 Investor Takeaway
The company disclosed quarterly financial results and auditor review, signaling ongoing transparency and regulatory compliance for investors.

Jubilant Pharmova's board approved unaudited standalone and consolidated financial results for Q1 FY2026 ending June 30, 2026, during a meeting held on August 10, 2026, from 5:30 p.m. to 7:05 p.m., and filed the results with stock exchanges along with the independent auditor's limited review report, making them available on the company's website.

📄 View Original Announcement (PDF)

📊 Stock Analysis — JUBLPHARMA ✨ Ask AI About This

About Jubilant Pharmova Limited (JUBLPHARMA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹14,469.9 Cr P/E: 40.9 ROE: 5.0% ROCE: 7.4% Div Yield: 0.55%

View full JUBLPHARMA stock details →

📡 Get AI alerts when JUBLPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track JUBLPHARMA — Free

💡 Ask AI about this filing

"What are the year-on-year revenue growth rates?" "How does the Q1 profit margin compare to previous quarters?" "What is the expected impact of the associate loss on future earnings?"

Ask AI Free →

📊 More JUBLPHARMA filings

See all JUBLPHARMA filings →

🔥 Also filed on 10 August 2026

TIMKEN Timken India Limited Financial Results DOMS DOMS Industries Limited Corporate Action HGS Hinduja Global Solutions Limited Financial Results SUNDRMFAST Sundram Fasteners Limited Financial Results AMJLAND Amj Land Holdings Limited Annual Report KANSAINER Kansai Nerolac Paints Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when JUBLPHARMA files new disclosures

Track JUBLPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track JUBLPHARMA — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd